Post a Comment Print Share on Facebook

Grifols obtains positive intermediate results in a Biotest bestseller

The German company publishes partial data of its phase III for its treatment for Fibrinogen deficiency.

- 16 reads.

Grifols obtains positive intermediate results in a Biotest bestseller

The German company publishes partial data of its phase III for its treatment for Fibrinogen deficiency

Grifols has achieved the first success with Biotest, its brand new acquisition for 1,453 million euros. The German company has recently announced promising intermediate results of its treatment for Fibrinogen deficiency (a protein

Keywords:
EmpresasCatalunyaCataluña
Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.